17h

Federal regulators this week will decide whether seven widely used peptides can be compounded by licensed pharmacies, though industry voices say consumer demand will likely stay strong no matter the outcome. The FDA’s Pharmacy Compounding Advisory Committee meets Thursday and Friday to consider adding the compounds to the agency’s 503A Bulks List, a move that […] The post FDA weighs peptide access as demand keeps climbing appeared first on Rolling Out .